Stereotaxis Q4 revenue $4.6M, down 37% YoY; full year adjusted net loss $10.2M; guides Q1 2024 revenue ~$7M

Stereotaxis, Inc.

Q4 2023 revenue $4.6M vs $7.3M prior year; full year revenue $26.8M vs $28.1M.
Q4 net loss $5.0M; full year adjusted net loss $10.2M vs $7.8M prior year.
Cash $20.6M; no debt; system backlog $14.7M entering 2024.
Q1 2024 revenue guidance ~$7.0M; expects double-digit revenue growth for full year 2024.
Regulatory submissions for robotic catheter in US/Europe; smaller robot pending EU clearance mid-2024; guidewire launch in 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Stereotaxis, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.

Period: the fourth quarter and full year ended December 31, 2023
Result: reported results

Exact text from the filing

On March 4, 2024, Stereotaxis, Inc. (the “Company”) issued a press release (the “Earnings Press Release”) setting forth its financial results for the 2023 fourth quarter and full year.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

Stereotaxis, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-008704

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.